You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
16 November 2020
MS Pharma is set to launch Enzymatica’s common cold spray, ColdZyme, under its registered trademarks in the Middle East and North Africa (MENA).
23 October 2020
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, under its established brands in France and Italy.
14 October 2020
Germany’s Stada has inlicensed exclusive rights to Enzymatica’s ViruProtect cold spray in an additional 14 countries including Poland, Russia and Ukraine.